542771 — Novateor Research Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹198.20m
- IN₹206.96m
- IN₹12.60m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.08 | 3.95 | 1.88 | 7.42 | 12.6 |
Cost of Revenue | |||||
Gross Profit | 3.78 | 1.44 | -0.248 | 2.14 | 2.96 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.16 | 6.28 | 6.13 | 14.9 | 16.8 |
Operating Profit | 1.92 | -2.33 | -4.26 | -7.44 | -4.23 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.95 | 0.266 | 0.166 | -2.6 | 0.395 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.19 | -0.079 | 0.118 | -2.28 | 0.367 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.19 | -0.079 | 0.118 | -2.28 | 0.367 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.19 | -0.079 | 0.118 | -2.28 | 0.367 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.452 | -0.016 | 0.02 | 0.161 | 0.08 |
Dividends per Share |